Cytocell Ltd. today announced the availability of a new molecular cytogenetic test designed to identify the presence of gene rearrangements associated with a specific form of non-small-cell lung ...

A novel approach to external quality assessment (EQA) using the Internet mimics the diagnostic situation so that multiple tests can be requested and EQA cases can be ‘tailor made’ to address a ...

Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...

Introduction: Prognosis of patients with newly diagnosed multiple myeloma (MM), a third most common hematological cancer, is dependent on baseline cytogenetics. However, little is known about the ...

Cytogenetics is the study of chromosomes, a vital tool to understanding how genetics play a role in the development and progression of certain diseases, as well as to predicting how a person will ...

Recent published studies have demonstrated the incremental value of the use of cell-free DNA for noninvasive prenatal testing with 100% sensitivity for trisomies 21 and 18 and a specificity of ≥99.7% ...

Reforms at the cytogenetics laboratory at Our Lady's Children's Hospital in Crumlin are important and necessary to meet best practice standards and to minimise risk and optimise patient care, the HSE ...

Javier Pinilla-Ibarz, MD, PhD: In terms of diagnosis and prognosis for chronic lymphocytic leukemia, we initially have to perform a technique called flow cytometry that will really indicate the ...

EuroGentest has announced a series of initiatives following the European Society of Human Genetics in Amsterdam designed to enhance and harmonise genetic testing across the EU. These include piloting ...

The appraisal committee considered evidence submitted by Pfizer and a review of this submission by the evidence review group (ERG). See the committee papers for full details of the evidence. Acute ...